SU GROUP HOLDINGS LTD (SUGP)

KYG8552M1096 - Common Stock

2.43  +0.39 (+19.12%)

After market: 2.4501 +0.02 (+0.83%)

Fundamental Rating

4

SUGP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. SUGP has an average financial health and profitability rating. SUGP has a expensive valuation and it also scores bad on growth.



5

1. Profitability

1.1 Basic Checks

In the past year SUGP was profitable.
SUGP had a negative operating cash flow in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of 17.21%, SUGP belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
The Return On Equity of SUGP (34.91%) is better than 95.24% of its industry peers.
The Return On Invested Capital of SUGP (29.13%) is better than 97.62% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SUGP is above the industry average of 9.89%.
The last Return On Invested Capital (29.13%) for SUGP is above the 3 year average (11.92%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.21%
ROE 34.91%
ROIC 29.13%
ROA(3y)7.54%
ROA(5y)N/A
ROE(3y)16.98%
ROE(5y)N/A
ROIC(3y)11.92%
ROIC(5y)N/A

1.3 Margins

SUGP's Profit Margin of 7.55% is fine compared to the rest of the industry. SUGP outperforms 78.57% of its industry peers.
With a decent Operating Margin value of 8.78%, SUGP is doing good in the industry, outperforming 63.10% of the companies in the same industry.
With a Gross Margin value of 28.21%, SUGP perfoms like the industry average, outperforming 44.05% of the companies in the same industry.
Industry RankSector Rank
OM 8.78%
PM (TTM) 7.55%
GM 28.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SUGP is creating value.
The number of shares outstanding for SUGP has been reduced compared to 1 year ago.
The debt/assets ratio for SUGP has been reduced compared to a year ago.

2.2 Solvency

SUGP has an Altman-Z score of 6.14. This indicates that SUGP is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SUGP (6.14) is better than 83.33% of its industry peers.
SUGP has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
SUGP has a Debt to Equity ratio of 0.06. This is in the better half of the industry: SUGP outperforms 77.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 6.14
ROIC/WACC3.29
WACC8.84%

2.3 Liquidity

SUGP has a Current Ratio of 1.78. This is a normal value and indicates that SUGP is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.78, SUGP is doing good in the industry, outperforming 61.90% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that SUGP should not have too much problems paying its short term obligations.
SUGP's Quick ratio of 1.03 is on the low side compared to the rest of the industry. SUGP is outperformed by 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.03

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.88% over the past year.
Looking at the last year, SUGP shows a quite strong growth in Revenue. The Revenue has grown by 9.44% in the last year.
EPS 1Y (TTM)20.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.64%
Revenue 1Y (TTM)9.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.57, the valuation of SUGP can be described as very reasonable.
94.05% of the companies in the same industry are more expensive than SUGP, based on the Price/Earnings ratio.
SUGP is valuated cheaply when we compare the Price/Earnings ratio to 29.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.57
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SUGP is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SUGP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SU GROUP HOLDINGS LTD

NASDAQ:SUGP (11/12/2024, 8:00:01 PM)

After market: 2.4501 +0.02 (+0.83%)

2.43

+0.39 (+19.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap33.17M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 11.57
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.21%
ROE 34.91%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.78%
PM (TTM) 7.55%
GM 28.21%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.78
Quick Ratio 1.03
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)20.88%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.44%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y